Psychedelic Groundbreakers Updates for the Psychedelics Industry

Psychedelics News

Psychedelic Groundbreakers

Culture, Industry, Psychedelic Groundbreakers

10 Oct 2025

After the Billion-Dollar Psychedelic Bet: Who’s Next for Big Pharma?

In the wake of Gilgamesh’s billion-dollar exit, a new wave of companies is emerging, smaller, stealthier, and far more scientifically disciplined than their first-wave predecessors. Their mission: harness the therapeutic...

By Madison Roberts

Breaking News, Press Releases, Psychedelic Groundbreakers, Psychedelic Titans, Science

28 Aug 2025

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

AbbVie’s quiet acquisition of Gilgamesh Pharmaceuticals, reportedly worth close to $1 billion, did more than make headlines. It signaled something far more significant: Big Pharma has officially entered the psychedelic-adjacent...

By Madison Roberts

Breaking News, Health & Wellness, Industry, Psychedelic Groundbreakers, Psychedelic Titans, Science

18 Aug 2025

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

But while traditional psychedelic developers dominate headlines, Enveric Biosciences (NASDAQ: ENVB) has stayed quietly in the background, focusing on an equally groundbreaking, but less flashy, approach: non-hallucinogenic neuroplastogens, small molecules...

By Madison Roberts

Breaking News, Industry, Press Releases, Psychedelic Groundbreakers, Science

23 Jul 2025

Enveric’s Latest Patent Signals a Clear Path Forward for PTSD Drug Development

This week, Enveric announced it has received a second U.S. patent allowance for compounds in its EVM401 Series, expanding its growing intellectual property fortress. These aren’t just any molecules —...

By Madison Roberts

Join Our Newsletter for Exclusive Updates, Stories, and More

Psychedelic Groundbreakers

13 Jan 2022

Psychedelic Groundbreakers: Entheo Ventures

This week's Psychedelic Groundbreaker is Entheo Ventures....

By Microdose

Psychedelic Groundbreakers

28 Oct 2021

Psychedelic Groundbreakers: Psylo

This week's Psychedelic Groundbreaker is Psylo, a pre-clinical biotech company designing new therapeutics that harness the potential of psychedelics....

By Microdose

Psychedelic Groundbreakers

21 Oct 2021

Psychedelic Groundbreakers: Silo Wellness

This week's Psychedelic Groundbreaker is Silo Wellness, a growth-oriented holding company focused on functional mushroom and psychedelic opportunities....

By Microdose

Psychedelic Groundbreakers

14 Oct 2021

Psychedelic Groundbreakers: Ketamine StartUp

This week's Psychedelic Groundbreaker is Ketamine StartUp....

By Microdose

Psychedelic Groundbreakers

30 Sep 2021

Psychedelic Groundbreakers: Integration Communications

Integration Communications envisions a world where psychedelics are safely, sustainably, effectively, and ethically integrated into our culture as tools for health, creativity, and human well-being....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result